Literature DB >> 15893415

Evidence for CEA release from human colon cancer cells by an endogenous GPI-PLD enzyme.

Fakhraddin Naghibalhossaini1, Padideh Ebadi.   

Abstract

Elevated carcinoembryonic antigen (CEA) blood levels are found in a wide variety of epithelial neoplasms. The precise mechanism of the spontaneous CEA release from normal and cancer cells has not been established yet. In this study we investigated 'in vitro' the role of an endogenous glycosylphosphatidyl inositol phospholipase D (GPI-PLD) in spontaneous CEA release from human colon carcinoma cells. We detected GPI-PLD-specific transcript expression in four human colorectal tumor cell lines, LS180, HT29, HT29/219, and SW742 by RT-PCR. Furthermore, CEA release could be activated and inhibited by incubation of LS180 cells with suramin and 1,10-phenanthroline, compounds known to activate and inhibit GPI-PLD activity, respectively. The results suggest a mechanism for the involvement of an endogenous GPI-PLD in spontaneous CEA release from human colon cancer cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15893415     DOI: 10.1016/j.canlet.2005.03.028

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Gold/WS2 nanocomposites fabricated by in-situ ultrasonication and assembling for photoelectrochemical immunosensing of carcinoembryonic antigen.

Authors:  Ye Hu; Yajiao Huang; Zhengguo Wang; Yanying Wang; Xiaoxue Ye; WingLeung Wong; Chunya Li; Dong Sun
Journal:  Mikrochim Acta       Date:  2018-12-01       Impact factor: 5.833

Review 2.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

3.  Regulation of carcinoembryonic antigen release from colorectal cancer cells.

Authors:  Abbas Pakdel; Fakhraddin Naghibalhossaini; Pooneh Mokarram; Mansooreh Jaberipour; Ahmad Hosseini
Journal:  Mol Biol Rep       Date:  2011-07-02       Impact factor: 2.316

Review 4.  Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review.

Authors:  Jiann-Sheng Su; Yu-Tso Chen; Ren-Ching Wang; Chun-Ying Wu; Shou-Wu Lee; Teng-Yu Lee
Journal:  World J Gastroenterol       Date:  2013-01-21       Impact factor: 5.742

5.  CRP and LOX-1: a Mechanism for Increasing the Tumorigenic Potential of Colorectal Cancer Carcinoma Cell Line.

Authors:  Mousa Ghazi-Khanloosani; Ahmad Reza Bandegi; Parviz Kokhaei; Mehdi Barati; Abbas Pakdel
Journal:  Pathol Oncol Res       Date:  2018-10-27       Impact factor: 3.201

6.  Microvesicles/exosomes as potential novel biomarkers of metabolic diseases.

Authors:  Günter Müller
Journal:  Diabetes Metab Syndr Obes       Date:  2012-08-07       Impact factor: 3.168

7.  The Clinical Significance of Glycoprotein Phospholipase D Levels in Distinguishing Early Stage Latent Autoimmune Diabetes in Adults and Type 2 Diabetes.

Authors:  Wen Qin; Yu-Zhen Liang; Bao-Yu Qin; Jia-Li Zhang; Ning Xia
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

8.  In silico post-SELEX screening and experimental characterizations for acquisition of high affinity DNA aptamers against carcinoembryonic antigen.

Authors:  Qiong-Lin Wang; Hui-Fang Cui; Jiang-Feng Du; Qi-Yan Lv; Xiaojie Song
Journal:  RSC Adv       Date:  2019-02-21       Impact factor: 4.036

9.  Highly Sensitive Love Mode Acoustic Wave Platform with SiO2 Wave-Guiding Layer and Gold Nanoparticles for Detection of Carcinoembryonic Antigens.

Authors:  Chong Li; Jikai Zhang; Haiyu Xie; Jingting Luo; Chen Fu; Ran Tao; Honglang Li; Yongqing Fu
Journal:  Biosensors (Basel)       Date:  2022-07-18

10.  Single-step cycle pulse operation of the label-free electrochemiluminescence immunosensor based on branched polypyrrole for carcinoembryonic antigen detection.

Authors:  Wenjuan Zhu; Qi Wang; Hongmin Ma; Xiaohui Lv; Dan Wu; Xu Sun; Bin Du; Qin Wei
Journal:  Sci Rep       Date:  2016-04-19       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.